New Vision Ventures
VC Fund
Beijing, China
New Vision Ventures is a venture capital firm specializing in seed, angel, and early stage investments. The firm typically invests in the healthcare sector includes medical services, medical diagnosis, hospital and clinics, new drug development, digital imaging, equipment and supplies, mobile health, health insurance, animal health and food safety.
- Total investments:
- 8
- Last investment:
- Lead investor:
- 25%
Last updated:
For AI agents: llms.txt
Industries New Vision Ventures invests in
Stages New Vision Ventures invests in
Countries New Vision Ventures invests in
Round sizes
Contacts
Round size
- Series A
- $3.1M–$13M
Investment Focus
Industry
- Health Care 5 (63%)
- Medical 2 (25%)
- Nutrition 1 (13%)
- Biotechnology 1 (13%)
- Pharmaceutical 1 (13%)
Stage
- Series A 4 (50%)
- Series B 2 (25%)
- Series C 1 (13%)
- Venture - Series Unknown 1 (13%)
Country
- China 5 (63%)
- Hong Kong 1 (13%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Bo Hu
Founding Partner
|
Founding Partner | Total investments: 0 | Find email | |
Peter Lu
Founding and Managing Partner
|
Founding and Managing Partner | Total investments: 0 | Find email | |
Tony Sun
Founding Partner
|
Founding Partner | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| i2Cool is a technology start-up that provides new and long-term solutions for a green, low-carbon society. | $12.8M / Series A / May 09, 2024 | ||
| Leads Biolabs is a pharmaceutical company that develops medicines and treatments for tumors. | Venture - Series Unknown / Apr 18, 2019 | ||
| Haoyunbang is a reproductive medicine service platform. | $5.8M / Series C / Dec 26, 2018 | ||
|
Imaging Union
|
Hefei Based Healthcare Start Up. | Series A / Jun 15, 2018 | |
| Oranger is a developer of portable wearable medical devices, focused on the treatment of medical-grade chronic respiratory diseases such as sleep apnea. | Series B / Jun 14, 2018 | ||
| WINCOME is a technology company that integrates medical nutrition services, nutrition system research and development, and sales. They provide intelligent nutrition management solutions for medical institutions at all levels, including government industry associations, health management institutions, Internet medical companies, and insurancecompanies. | $3.1M / Series A / Dec 27, 2017 | ||
| Leads Biolabs is a pharmaceutical company that develops medicines and treatments for tumors. | Series A / Jul 03, 2017 | ||
| Haoyunbang is a reproductive medicine service platform. | Series B / May 08, 2017 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does New Vision Ventures invest in?
New Vision Ventures invests primarily in Health Care, Medical and Nutrition startups, most often at Series A and Series B stage. Most of the 8 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does New Vision Ventures invest in?
New Vision Ventures typically joins rounds of $3.1M–$13M at Series A. These are whole funding-round sizes, not New Vision Ventures's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds New Vision Ventures took part in.
How do I contact New Vision Ventures?
Public channels for New Vision Ventures include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at New Vision Ventures?
The team at New Vision Ventures includes Bo Hu (Founding Partner), Peter Lu (Founding and Managing Partner) and Tony Sun (Founding Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
